Largest health care biotech companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 24 health care biotech companies ranked by total liabilities, at CZK 1.82T, ahead of Gilead Sciences (CZK 810.6B) and Biogen (CZK 249B). Figures as of 19 Nov 2026, 21:46 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AmgenCZK 1.82T
- Median
- CZK 15.7B
- Combined market value
- CZK 18.45T
- Countries
- 5
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | CZK 1.82T | CZK 5.29T | CZK 9,771.56 | 1.14% down | 32% up | ||
| 2 | Gilead SciencesGILD · Health Care | CZK 810.6B | CZK 4.6T | CZK 3,708.26 | 1.45% down | 35% up | ||
| 3 | BiogenBIIB · Health Care | CZK 249B | CZK 813.5B | CZK 5,503.04 | 1.70% down | 49% up | ||
| 4 | ModernaMRNA · Health Care | CZK 82.1B | CZK 1.8T | CZK 4,438.64 | 1.29% up | 780% up | ||
| 5 | BioNTechBNTX · Health Care | CZK 68.3B | CZK 449.3B | CZK 1,812.15 | 2.26% down | 14% down | ||
| 6 | QiagenQGEN · Health Care | CZK 55.7B | CZK 228.2B | CZK 1,105.15 | 0.14% up | 9% up | ||
| 7 | Halozyme TherapeuticsHALO · Health Care | CZK 55.1B | CZK 236.2B | CZK 2,071.80 | 2.88% down | 39% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | CZK 30.7B | CZK 352.9B | CZK 3,486.91 | 3.85% down | 17% up | ||
| 9 | argenxARGX · Health Care | CZK 30.3B | CZK 1.32T | CZK 20,977.16 | 0.08% up | 2% up | ||
| 10 | ImmunityBioIBRX · Health Care | CZK 22.3B | CZK 155.6B | CZK 146.30 | 1.94% down | 232% up | ||
| 11 | RepligenRGEN · Health Care | CZK 18.8B | CZK 242.4B | CZK 3,791.98 | 1.38% down | 12% up | ||
| 12 | Revolution MedicinesRVMD · Health Care | CZK 16.1B | CZK 767.9B | CZK 3,550.16 | 0.24% down | 129% up | ||
| 13 | ExelixisEXEL · Health Care | CZK 15.2B | CZK 357.7B | CZK 1,465.89 | 3.60% down | 63% up | ||
| 14 | Bio-TechneTECH · Health Care | CZK 10.7B | CZK 254.3B | CZK 1,618.87 | 0.07% down | 24% up | ||
| 15 | CRISPR TherapeuticsCRSP · Health Care | CZK 7.6B | CZK 84.1B | CZK 866.89 | 3.14% down | 18% down | ||
| 16 | VaxcytePCVX · Health Care | CZK 7.1B | CZK 205.7B | CZK 1,299.55 | 0.27% down | 23% up | ||
| 17 | Adaptive BiotechnologiesADPT · Health Care | CZK 6.4B | CZK 101.1B | CZK 624.61 | 1.44% down | 74% up | ||
| 18 | Kodiak SciencesKOD · Health Care | CZK 4.3B | CZK 142.6B | CZK 2,180.02 | 0.09% up | 399% up | ||
| 19 | Twist BioscienceTWST · Health Care | CZK 3.8B | CZK 169.5B | CZK 2,485.53 | 4.07% down | 346% up | ||
| 20 | Kymera TherapeuticsKYMR · Health Care | CZK 3.6B | CZK 227B | CZK 2,658.55 | 1.44% down | 87% up | ||
| 21 | Scholar Rock HoldingSRRK · Health Care | CZK 3.5B | CZK 136.8B | CZK 1,121.63 | 4.94% up | 26% up | ||
| 22 | Krystal BiotechKRYS · Health Care | CZK 2.5B | CZK 208.4B | CZK 7,032.62 | 0.15% up | 54% up | ||
| 23 | ImmunovantIMVT · Health Care | CZK 2.3B | CZK 149.9B | CZK 724.15 | 1.96% down | 46% up | ||
| 24 | CG OncologyCGON · Health Care | CZK 868.2M | CZK 162.9B | CZK 1,823.73 | 2.38% up | 97% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2678 CZK).
Questions and answers
Which health care biotech companies rank first by total liabilities?
Amgen (CZK 1.82T), Gilead Sciences (CZK 810.6B) and Biogen (CZK 249B) are the top three of the 24 health care biotech companies ranked by total liabilities as of 19 Nov 2026, 21:46 UTC.
How many health care biotech companies are in this ranking?
24 are ranked by total liabilities.
What are these health care biotech companies worth together?
The 24 health care biotech companies ranked by total liabilities have a combined market value of CZK 18.45T as of 19 Nov 2026, 21:46 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care biotech companies by total liabilities”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.